Psychiatric medications are a cornerstone in the treatment of various mental health disorders, offering relief and improved quality of life for many individuals. However, like all medications, they come with potential risks and side effects, some of which may not be fully understood or might emerge over time. This article explores the lesser-known dangers associated with psychiatric medications, underpinned by scientific research, to foster a balanced understanding of their use in mental health treatment.
Tardive Dyskinesia from Antipsychotics
One of the more severe side effects associated with long-term use of antipsychotic medications is Tardive Dyskinesia (TD), a condition characterised by involuntary, repetitive body movements. According to Correll and Schenk (2008) in the Journal of the American Medical Association, TD can be persistent and potentially irreversible, even after discontinuation of the medication.
Antidepressants and Increased Suicide Risk
The relationship between antidepressants and an increased risk of suicide, especially in children and adolescents, has been a concern. The U.S. Food and Drug Administration (FDA) issued a black box warning in 2004 after a review highlighted that young individuals taking antidepressants had a higher risk of suicidal thoughts and behaviors (Hammad et al., 2006, Archives of General Psychiatry). This risk underscores the importance of careful monitoring during the initial stages of treatment.
Benzodiazepines and Dependence
Benzodiazepines, often prescribed for anxiety and insomnia, carry a risk of dependence and withdrawal symptoms. Long-term use can lead to tolerance, necessitating higher doses to achieve the same therapeutic effect, and abrupt discontinuation can result in withdrawal symptoms. According to Baldwin et al. (2013) in Addiction, the potential for dependence and withdrawal highlights the need for judicious use and careful management of these medications.
Cognitive Decline Associated with Polypharmacy
Polypharmacy, the use of multiple medications, is common in treating psychiatric conditions, particularly in older adults. This practice can increase the risk of adverse drug interactions and cognitive decline. A study by Best et al. (2019) in the British Journal of Clinical Pharmacology found that polypharmacy was associated with a higher risk of cognitive impairment, emphasising the need for cautious medication management.
Weight Gain and Metabolic Syndrome
Many psychiatric medications, especially certain antipsychotics and antidepressants, are associated with weight gain and metabolic changes that can lead to metabolic syndrome, a cluster of conditions increasing the risk of heart disease, stroke, and type 2 diabetes. De Hert et al. (2011) in World Psychiatry discussed these metabolic side effects as significant concerns that require monitoring and management in patients undergoing psychiatric medication treatment.
Conclusion
While psychiatric medications are an essential tool in managing mental health disorders, their potential unknown or lesser-known dangers necessitate a careful and informed approach. It is crucial for healthcare providers and patients to engage in open dialogue about the benefits and risks of psychiatric medications, consider non-pharmacological treatments when appropriate, and implement regular monitoring for side effects. Understanding and mitigating these risks can enhance the safe and effective use of psychiatric medications in mental health care.
References
- Correll, C. U., & Schenk, E. M. (2008). Tardive dyskinesia and new antipsychotics. Journal of the American Medical Association.
- Hammad, T. A., Laughren, T., & Racoosin, J. A. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry.
- Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2013). Benzodiazepines: Risks and benefits. A reconsideration. Addiction.
- Best, E. L., Avenell, A., Bhattacharya, S., & Simpson, W. G. (2019). Does polypharmacy cause cognitive impairment in older people? The case for deprescribing. British Journal of Clinical Pharmacology.
- De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2011). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. World Psychiatry.
How to get in touch
If you or your patient/NDIS clients need immediate mental healthcare assistance, feel free to get in contact with us on 1800 NEAR ME – admin@therapynearme.com.au.
